Stay updated on KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new 'Study Status' entry on 2026-03-25 and version 9 on 2026-03-23. Deleted the 2025-05-29 entry.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded revision: v3.5.0; removed revision: v3.4.3 from the record history.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the Record History.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded revision entry v3.4.2 and removed v3.4.1 from the Record History page, updating the displayed site version history.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded a new revision entry (v3.4.1) to the record history and removed a funding-status notice along with an older revision (v3.4.0). These are administrative updates to the page's history and do not affect the underlying study data or public-facing trial information.SummaryDifference0.8%

- Check72 days agoChange DetectedA site-wide notice about government funding and operating status was added at the top of the page, but the study record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.